These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9371332)

  • 1. Carbapenem resistance in a clinical isolate of Citrobacter freundii.
    Mainardi JL; Mugnier P; Coutrot A; Buu-Hoï A; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2352-4. PubMed ID: 9371332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
    Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.
    Zhang R; Yang L; Cai JC; Zhou HW; Chen GX
    J Med Microbiol; 2008 Mar; 57(Pt 3):332-337. PubMed ID: 18287296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of a Ceftazidime-Avibactam-Resistant
    Castanheira M; Arends SJR; Davis AP; Woosley LN; Bhalodi AA; MacVane SH
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30258039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
    Li G; Wei Q; Wang Y; Du X; Zhao Y; Jiang X
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):575-80. PubMed ID: 21153909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
    Dib C; Trias J; Jarlier V
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):979-86. PubMed ID: 8654449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.
    Raimondi A; Traverso A; Nikaido H
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1174-80. PubMed ID: 1656855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First detection of VIM-4 metallo-β-lactamase-producing Citrobacter freundii in China.
    Wei Y; Wang J
    Ann Lab Med; 2013 Jan; 33(1):84-5. PubMed ID: 23301229
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.
    Yigit H; Anderson GJ; Biddle JW; Steward CD; Rasheed JK; Valera LL; McGowan JE; Tenover FC
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3817-22. PubMed ID: 12435682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.
    Schmidtke AJ; Hanson ND
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2030-7. PubMed ID: 16723562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
    Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
    J Clin Microbiol; 2000 Sep; 38(9):3299-305. PubMed ID: 10970374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae.
    Piddock LJ; Turner HL
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1186-91. PubMed ID: 1291320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities.
    Cornaglia G; Guan L; Fontana R; Satta G
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1902-8. PubMed ID: 1416880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.
    Goessens WH; van der Bij AK; van Boxtel R; Pitout JD; van Ulsen P; Melles DC; Tommassen J
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3941-9. PubMed ID: 23733461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.